S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer—A Randomized Clinical Study
Author:
Affiliation:
1. Department of Oncology, Qingdao Central Hospital, Qingdao University, China
2. Pingdu People’s Hospital, Qingdao, China
3. Department of Oncology, PLA 971 Hospital, Qingdao City, China
Abstract
Publisher
SAGE Publications
Subject
Oncology,Hematology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/1073274820932004
Reference19 articles.
1. What's New in SCLC? A Review
2. Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
3. Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
4. No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials
5. The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline;Journal of Clinical Oncology;2023-12-10
2. Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.;Seminars in Oncology;2022-10
3. Parotid metastases from primary lung cancer: Case series and systematic review of the features;Frontiers in Oncology;2022-08-25
4. Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer;Analytical Cellular Pathology;2022-06-16
5. “Highly Exposed Chinese Herbal Medicine” Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study;Dose-Response;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3